1. Roles of cancer/testis antigens (CTAs) in breast cancer
   Yongfei Li et al, 2017, Cancer Letters CrossRef
2. Protease-triggered bioresponsive drug delivery for the targeted theranostics of malignancy
   Yanan Li et al, 2021, Acta Pharmaceutica Sinica B CrossRef
3. Novel Oxovanadium Complex VO(hntdtsc)(NPIP): Anticancer Activity and Mechanism of Action on HeLa Cells
   Yinliang Bai et al, 2021, Frontiers in Pharmacology CrossRef
4. Effects of IncRNA PROX1-AS1 on Proliferation, Migration, Invasion and Apoptosis of Lung Cancer Cells by Regulating MiR-1305
   Quanneng Zhao et al, 2022, Journal of Healthcare Engineering CrossRef
5. RETRACTED: Znhit1 inhibits breast cancer by up-regulating PTEN to deactivate the PI3K/Akt/mTOR pathway
   Chunguo Cui et al, 2019, Life Sciences CrossRef
6. miR-4709-3p Inhibits Cell Proliferation by Downregulating TSP50 Expression in Breast Cancer Cells
   Ying Wang et al, 2021, DNA and Cell Biology CrossRef
7. Effect of miR-1244 on cisplatin-treated non-small cell lung cancer via MEF2D expression
   Guang-Jian Li et al, 2017, Oncology Reports CrossRef
8. RALY may cause an aggressive biological behavior and a dismal prognosis in non-small-cell lung cancer
   Guanchu Song et al, 2020, Experimental Cell Research CrossRef
9. TSP50 promotes hepatocyte proliferation and tumour formation by activating glucose‐6‐phosphate dehydrogenase (G6PD)
   Xiaojun Zhang et al, 2021, Cell Proliferation CrossRef
10. Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer
    Ping Yang et al, 2022, Frontiers in Oncology CrossRef
11. In vivo methods for acute modulation of gene expression in the central nervous system
    Andrzej W. Cwetsch et al, 2018, Progress in Neurobiology CrossRef